First evidence of SOX2 mutations in Peters' anomaly: Lessons from molecular screening of 95 patients
暂无分享,去创建一个
L. Bouneau | P. Calvas | N. Chassaing | D. Lacombe | L. Faivre | H. Dollfus | V. Gaston | C. Le Caignec | B. Isidor | A. Dieux | G. Le Guyader | C. Ayuso | J. Amiel | F. Prieur | B. Laudier | T. Attié-Bitach | S. Odent | C. Vincent‐Delorme | M. Rio | D. Dupin-Deguine | G. Le Meur | J. Kaplan | J. Rozet | O. Boute | J. Plaisancié | L. Fares-Taie | F. Laffargue | M. Nizon | L. Pinson | V. Soler | T. Busa | G. Morel | D. Thouvenin | E. Cottereau | M. Aubert-Mucca | S. Naudion | C. Jeanton-Scaramouche | C. Vanlerberghe | B. Chesneau | J. Pechméja | F. Fremont | C. Lesage | S. Boussion | V. Lambert | Marta Corton-Pérez | Simon Boussion | Sophie Naudion
[1] E. Sorokina,et al. Comprehensive phenotypic and functional analysis of dominant and recessive FOXE3 alleles in ocular developmental disorders , 2021, Human molecular genetics.
[2] Y. Wakamatsu,et al. The many faces of Sox2 function in neural crest development , 2020, Development, growth & differentiation.
[3] Brenda L. Bohnsack,et al. Genetics Underlying the Interactions between Neural Crest Cells and Eye Development , 2020, Journal of developmental biology.
[4] D. Stephens,et al. Long-Term Visual Outcomes and Clinical Course of Patients With Peters Anomaly. , 2020, Cornea.
[5] P. Calvas,et al. Confirmation of FZD5 implication in a cohort of 50 patients with ocular coloboma , 2020, European Journal of Human Genetics.
[6] M. Cowley,et al. Revealing hidden genetic diagnoses in the ocular anterior segment disorders , 2020, Genetics in Medicine.
[7] Y. Shin,et al. Effect of SOX2 Repression on Corneal Endothelial Cells , 2020, International journal of molecular sciences.
[8] M. Tekin,et al. Spectrum of Genetic Variants Associated with Anterior Segment Dysgenesis in South Florida , 2020, Genes.
[9] G. Arno,et al. The Spectrum of PAX6 Mutations and Genotype-Phenotype Correlations in the Eye , 2019, Genes.
[10] E. Zackai,et al. Novel variants in CDH2 are associated with a new syndrome including Peters anomaly , 2019, Clinical genetics.
[11] J. Weiss,et al. Clinical and genetic update of corneal dystrophies. , 2019, Experimental eye research.
[12] Chen Luxenburg,et al. SOX2 Regulates P63 and Stem/Progenitor Cell State in the Corneal Epithelium , 2019, Stem cells.
[13] A. Levin,et al. Ophthalmic manifestations associated with RARB mutations. , 2019, Clinical dysmorphology.
[14] P. Calvas,et al. Implication of non-coding PAX6 mutations in aniridia , 2018, Human Genetics.
[15] J. Grigg,et al. Phenotype–genotype correlations and emerging pathways in ocular anterior segment dysgenesis , 2018, Human Genetics.
[16] S. Mundlos,et al. Structural variation in the 3D genome , 2018, Nature Reviews Genetics.
[17] Colin N. Dewey,et al. Zebrafish zic2 controls formation of periocular neural crest and choroid fissure morphogenesis. , 2017, Developmental biology.
[18] Y. Matsubara,et al. SOX2 nonsense mutation in a patient clinically diagnosed with non-syndromic hypogonadotropic hypogonadism. , 2017, Endocrine journal.
[19] J. Salazar,et al. Goniodysgenesis variability and activity of CYP1B1 genotypes in primary congenital glaucoma , 2017, PloS one.
[20] M. Brown,et al. Contribution of Mutations in Known Mendelian Glaucoma Genes to Advanced Early-Onset Primary Open-Angle Glaucoma. , 2017, Investigative ophthalmology & visual science.
[21] E. Weh,et al. 8q21.11 microdeletion in two patients with syndromic peters anomaly , 2016, American journal of medical genetics. Part A.
[22] J. Escribano,et al. Functional characterization of eight rare missense CYP1B1 variants involved in congenital glaucoma and their association with null genotypes , 2016, Acta ophthalmologica.
[23] N. Katsanis,et al. Targeted resequencing identifies PTCH1 as a major contributor to ocular developmental anomalies and extends the SOX2 regulatory network , 2016, Genome research.
[24] H. Rehm,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[25] R. Zori,et al. A Case of 22q11.2 Deletion Syndrome with Peters Anomaly, Congenital Glaucoma, and Heterozygous Mutation in CYP1B1 , 2015, Ophthalmic genetics.
[26] M. Maheshwari,et al. Whole exome analysis identifies dominant COL4A1 mutations in patients with complex ocular phenotypes involving microphthalmia , 2014, Clinical genetics.
[27] A. Toutain,et al. Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia , 2014, Clinical genetics.
[28] K. David,et al. Whole exome sequence analysis of Peters anomaly , 2014, Human Genetics.
[29] D. Bick,et al. Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes , 2014, Clinical genetics.
[30] G. Zaidman,et al. Incidence of Peters Anomaly and Congenital Corneal Opacities Interfering With Vision in the United States , 2014, Cornea.
[31] H. Wada,et al. Mutation spectrum and phenotypic variation in nine patients with SOX2 abnormalities , 2014, Journal of Human Genetics.
[32] A. Jauch,et al. Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome , 2014, Orphanet Journal of Rare Diseases.
[33] Margaret B. Fish,et al. Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia. , 2013, American journal of human genetics.
[34] D. Fitzpatrick,et al. Clinical and mutation analysis of 51 probands with anophthalmia and/or severe microphthalmia from a single center , 2013, Molecular genetics & genomic medicine.
[35] K. H. Shin,et al. Comparison between aniridia with and without PAX6 mutations: clinical and molecular analysis in 14 Korean patients with aniridia. , 2012, Ophthalmology.
[36] A. Sauer,et al. [Axenfeld-Rieger syndrome]. , 2012, Journal francais d'ophtalmologie.
[37] D. Lazzaro,et al. Peters Anomaly: Review of the Literature , 2011, Cornea.
[38] A. Cvekl,et al. Retinoic acid signaling in mammalian eye development. , 2009, Experimental eye research.
[39] D. Lacombe,et al. Twelve new patients with 13q deletion syndrome: genotype-phenotype analyses in progress. , 2009, European journal of medical genetics.
[40] G. Gole,et al. Anterior segment mesenchymal dysgenesis in a large Australian family is associated with the recurrent 17 bp duplication in PITX3 , 2008, Molecular vision.
[41] R. Lovell-Badge,et al. SOX2 plays a critical role in the pituitary, forebrain, and eye during human embryonic development. , 2008, The Journal of clinical endocrinology and metabolism.
[42] M. Harissi-Dagher,et al. Anterior Segment Dysgenesis: Peters Anomaly and Sclerocornea , 2008, International ophthalmology clinics.
[43] A. Wyatt,et al. SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions , 2007, British Journal of Ophthalmology.
[44] V. van Heyningen,et al. Developmental malformations of the eye: the role of PAX6, SOX2 and OTX2 , 2006, Clinical genetics.
[45] C. Hayward,et al. Mutations in SOX2 cause anophthalmia , 2003, Nature Genetics.
[46] B. Kerr,et al. Domain disruption and mutation of the bZIP transcription factor, MAF, associated with cataract, ocular anterior segment dysgenesis and coloboma. , 2002, Human molecular genetics.
[47] Y. Ogura,et al. Histopathological examination of two cases of anterior staphyloma associated with Peters' anomaly and persistent hyperplastic primary vitreous , 2001, The British journal of ophthalmology.
[48] I. Hanson,et al. Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly , 1994, Nature Genetics.